1. Home
  2. ARWR vs BFH Comparison

ARWR vs BFH Comparison

Compare ARWR & BFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • BFH
  • Stock Information
  • Founded
  • ARWR 2003
  • BFH 1996
  • Country
  • ARWR United States
  • BFH United States
  • Employees
  • ARWR N/A
  • BFH N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • BFH Business Services
  • Sector
  • ARWR Health Care
  • BFH Consumer Discretionary
  • Exchange
  • ARWR Nasdaq
  • BFH Nasdaq
  • Market Cap
  • ARWR 2.5B
  • BFH 2.3B
  • IPO Year
  • ARWR 1993
  • BFH N/A
  • Fundamental
  • Price
  • ARWR $18.57
  • BFH $58.51
  • Analyst Decision
  • ARWR Buy
  • BFH Hold
  • Analyst Count
  • ARWR 11
  • BFH 19
  • Target Price
  • ARWR $45.33
  • BFH $48.63
  • AVG Volume (30 Days)
  • ARWR 997.3K
  • BFH 800.2K
  • Earning Date
  • ARWR 11-26-2024
  • BFH 10-24-2024
  • Dividend Yield
  • ARWR N/A
  • BFH 1.44%
  • EPS Growth
  • ARWR N/A
  • BFH N/A
  • EPS
  • ARWR N/A
  • BFH 6.25
  • Revenue
  • ARWR $19,648,000.00
  • BFH $2,467,000,000.00
  • Revenue This Year
  • ARWR N/A
  • BFH N/A
  • Revenue Next Year
  • ARWR $100.95
  • BFH $1.04
  • P/E Ratio
  • ARWR N/A
  • BFH $9.27
  • Revenue Growth
  • ARWR N/A
  • BFH N/A
  • 52 Week Low
  • ARWR $17.05
  • BFH $26.58
  • 52 Week High
  • ARWR $39.83
  • BFH $63.01
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 35.87
  • BFH 60.79
  • Support Level
  • ARWR $21.20
  • BFH $56.28
  • Resistance Level
  • ARWR $22.03
  • BFH $61.67
  • Average True Range (ATR)
  • ARWR 0.87
  • BFH 2.17
  • MACD
  • ARWR -0.04
  • BFH 0.37
  • Stochastic Oscillator
  • ARWR 0.76
  • BFH 66.57

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About BFH Bread Financial Holdings Inc.

Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains minority interest in its recently spun-off LoyaltyOne division, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.

Share on Social Networks: